Letermovir for cytomegalovirus prophylaxis in lung transplant recipients: A promising shift toward reduced myelotoxicity

MeSH terms

• Acetates* / administration & dosage
• Acetates* / adverse effects
• Acetates* / therapeutic use
• Antiviral Agents* / adverse effects
• Antiviral Agents* / therapeutic use
• Cytomegalovirus / drug effects
• Cytomegalovirus Infections* / prevention & control
• Humans
• Lung Transplantation* / adverse effects
• Quinazolines* / adverse effects
• Quinazolines* / therapeutic use
• Transplant Recipients
• Triazoles / administration & dosage
• Triazoles / adverse effects
• Triazoles / therapeutic use